![Enrique Poradosu](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Enrique Poradosu
Fondateur chez
NUVECTIS PHARMA, INC.
Fortune : 18 M $ au 31/05/2026
Profil
Dr. Enrique Poradosu is a Chief Scientific & Business Officer, Executive VP at Nuvectis Pharma, Inc. Dr. Poradosu was previously employed as a Senior VP-Business & Scientific Strategy by Stemline Therapeutics, Inc. and a Vice President-Business & Scientific Strategy by Keryx Biopharmaceuticals, Inc. He received his undergraduate degree from The Hebrew University of Jerusalem and a doctorate degree from The Hebrew University of Jerusalem.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
NUVECTIS PHARMA, INC. 6,81 % | 13/04/2026 | 1 806 319 ( 6,81 % ) | 18 M $ | 31/05/2026 |
Postes actifs de Enrique Poradosu
| Sociétés | Poste | Début |
|---|---|---|
| NUVECTIS PHARMA, INC. | Fondateur | 27/07/2020 |
Anciens postes connus de Enrique Poradosu
| Sociétés | Poste | Fin |
|---|---|---|
| STEMLINE THERAPEUTICS, INC. | Corporate Officer/Principal | 01/12/2020 |
| KERYX BIOPHARMACEUTICALS | Directeur Technique/Scientifique/R&D | 01/01/2016 |
Formation de Enrique Poradosu
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
37
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Keryx Biopharmaceuticals, Inc.
 Keryx Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which focuses on therapies for patients with renal disease | Health Technology |
Stemline Therapeutics, Inc.
 Stemline Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel oncology therapeutics | Health Technology |
The Hebrew University of Jerusalem
 The Hebrew University of Jerusalem Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nuvectis Pharma, Inc.
 Nuvectis Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops medicines for treatment of cancer | Health Technology |
